Circle Pharma Appoints Rob Lauzen as Chief Financial Officer
November 3, 2025
Circle Pharma, Inc., a clinical-stage biopharmaceutical company developing next-generation macrocycle therapeutics to target cancer, announced the appointment of Rob Lauzen as its new Chief Financial